6533b85dfe1ef96bd12bf1e9
RESEARCH PRODUCT
Application of polymeric nanoparticles in immunotherapy.
Maria Luisa BondìEmanuela Fabiola Craparosubject
business.industrydendritic cellPolymersmedicine.medical_treatmentImmunologyCancerAdeptImmunotherapyPolymeric nanoparticlesmedicine.diseaseImmune systemantigenpolymeric nanoparticlesDrug Delivery SystemsCancer immunotherapyAntigenSettore CHIM/09 - Farmaceutico Tecnologico ApplicativomedicineCancer researchImmunology and AllergyAnimalsHumansNanoparticlesImmunotherapybusinessdescription
Purpose of review The purpose of the present review is to underline the importance of nanoparticulate carriers, such as polymeric nanoparticles, in the future development of safe and effective formulation in the field of immunotherapy against infectious diseases and cancer. Recent findings Polymeric nanoparticles can modulate the immune response, that is, by targeting antigens to dendritic cells that possess a crucial role in initiating immune responses, and might be potentially useful in immunotherapy. Summary In the last decades, significant progress in research and clinics has been made to offer possible innovative therapeutics for the management of infectious diseases and cancer. Polymeric nanoparticles are particularly adept at facilitating immunotherapeutic approaches because they can be engineered to have different physical properties, encapsulated agents, and surface ligands. Moreover, these systems are administrable for all routes, are capable of being actively taken up by dendritic cells and have shown promising potential in systemic and mucosal immunotherapy. Here, some recent findings on these systems, in their potential applications for infectious and cancer immunotherapy, are reported.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2012-10-26 | Current opinion in allergy and clinical immunology |